L2, the minor capsid protein of papillomavirus von Wang, Joshua W, Roden, Richard B.S

Volltext

Immunologic Control of Mus musculus Papillomavirus Type 1 von Wang, Joshua W, Jiang, Rosie, Peng, Shiwen, Chang, Yung-Nien, Hung, Chien-Fu, Roden, Richard B S

Volltext

Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types von Kwak, Kihyuck, Jiang, Rosie, Wang, Joshua W, Jagu, Subhashini, Kirnbauer, Reinhard, Roden, Richard B S

Volltext

Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions von Wang, Joshua W, Jagu, Subhashini, Wang, Chenguang, Kitchener, Henry C, Daayana, Sai, Stern, Peter L, Pang, Susana, Day, Patricia M, Huh, Warner K, Roden, Richard B S

Volltext

Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer von Peng, Shiwen, Wang, Joshua W, Karanam, Balasubramanyam, Wang, Chenguang, Huh, Warner K, Alvarez, Ronald D, Pai, Sara I, Hung, Chien-fu, Wu, T-C, Roden, Richard B S

Volltext

A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer von Anchoori, Ravi K., Karanam, Balasubramanyam, Peng, Shiwen, Wang, Joshua W., Jiang, Rosie, Tanno, Toshihiko, Orlowski, Robert Z., Matsui, William, Zhao, Ming, Rudek, Michelle A., Hung, Chien-fu, Chen, Xiang, Walters, Kylie J., Roden, Richard B.S.

Volltext

Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation von Kwak, Kihyuck, Jiang, Rosie, Jagu, Subhashini, Wang, Joshua W, Wang, Chenguang, Christensen, Neil D, Roden, Richard B S

Volltext

RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer von Olczak, Pola, Matsui, Ken, Wong, Margaret, Alvarez, Jade, Lambert, Paul, Christensen, Neil D, Hu, Jiafen, Huber, Bettina, Kirnbauer, Reinhard, Wang, Joshua W, Roden, Richard B S

Volltext

Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus von Wang, Joshua W, Wu, Wai Hong, Huang, Tsui-Chin, Wong, Margaret, Kwak, Kihyuck, Ozato, Keiko, Hung, Chien-Fu, Roden, Richard B S

Volltext

Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection von Jiang, Rosie T, Wang, Joshua W, Peng, Shiwen, Huang, Tsui-Chin, Wang, Chenguang, Cannella, Fabiana, Chang, Yung-Nien, Viscidi, Raphael P, Best, Simon R A, Hung, Chien-Fu, Roden, Richard B S

Volltext

Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies von Wang, Joshua W, Jagu, Subhashini, Kwak, Kihyuck, Wang, Chenguang, Peng, Shiwen, Kirnbauer, Reinhard, Roden, Richard B.S

Volltext

Immunoprevention of human papillomavirus-associated malignancies von Wang, Joshua W, Hung, Chein-Fu, Huh, Warner K, Trimble, Cornelia L, Roden, Richard B S

Volltext

Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17–36 epitopes von Jagu, Subhashini, Karanam, Balusubramanyam, Wang, Joshua W, Zayed, Hatem, Weghofer, Margit, Brendle, Sarah A, Balogh, Karla K, Tossi, Kerstin Pino, Roden, Richard B.S, Christensen, Neil D

Volltext

Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies von Wang, Joshua W, Jagu, Subhashini, Wu, Wai-Hong, Viscidi, Raphael P, Macgregor-Das, Anne, Fogel, Jessica M, Kwak, Kihyuck, Daayana, Sai, Kitchener, Henry, Stern, Peter L, Gravitt, Patti E, Trimble, Cornelia L, Roden, Richard B S

Volltext

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells von Peng, Shiwen, Song, Liwen, Knoff, Jayne, Wang, Joshua W, Chang, Yung-Nien, Hannaman, Drew, Wu, T-C, Alvarez, Ronald D, Roden, Richard Bs, Hung, Chien-Fu

Volltext

Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease von Peng, Shiwen, Qiu, Jin, Yang, Andrew, Yang, Benjamin, Jeang, Jessica, Wang, Joshua W, Chang, Yung-Nien, Brayton, Cory, Roden, Richard B S, Hung, Chien-Fu, Wu, T-C

Volltext

Production of Furin‐Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1‐ or L2‐Specific Antibodies von Wang, Joshua W., Matsui, Ken, Pan, Yuanji, Kwak, Kihyuck, Peng, Shiwen, Kemp, Troy, Pinto, Ligia, Roden, Richard B.S.

Volltext

Abstract 2364: Spontaneous and vaccine-induced clearance of Mus Musculus Papillomavirus1 (MusPV1) infection von Jiang, Rosie T., Wang, Joshua W., Peng, Shiwen, Hung, Chien-Fu, Roden, Richard B.S

Volltext

Immunologic Control of Mus musculus Papillomavirus Type 1: e1005243 von Wang, Joshua W, Jiang, Rosie, Peng, Shiwen, Chang, Yung-Nien, Hung, Chien-Fu, Roden, Richard BS

Volltext

Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types: e97232 von Kwak, Kihyuck, Jiang, Rosie, Wang, Joshua W, Jagu, Subhashini, Kirnbauer, Reinhard, Roden, Richard BS

Volltext